ClinConnect ClinConnect Logo
Search / Trial NCT06897969

Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment

Launched by NISHTAR MEDICAL UNIVERSITY · Mar 20, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

Keloid Vancouver Scar Scale Triamcinolone Verapamil Intralesional Injection

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • size of keloid1-5 cm,
  • on any site of the body,
  • duration less then five years and
  • baseline Vancouver scar score of more the or equal to 5
  • Exclusion Criteria:
  • Pregnant or lactating women,
  • family history of keloids,
  • acromegaly, and
  • congestive cardiac diseases

Trial Officials

Dr. Aliya Akhtar, FCPS

Study Director

Nishtar Medical University

About Nishtar Medical University

Nishtar Medical University is a prestigious institution dedicated to advancing medical education, research, and healthcare in Pakistan. With a commitment to excellence, the university actively engages in clinical trials to explore innovative treatments and enhance patient care. By fostering collaboration among researchers, healthcare professionals, and academic institutions, Nishtar Medical University aims to contribute significantly to the scientific community and improve health outcomes through rigorous clinical research and ethical practices.

Locations

Multan, Punjab, Pakistan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported